Vienna, Austria

Christine Schmatz


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Christine Schmatz: A Trailblazer in HIV Vaccine Development

Introduction

Christine Schmatz is a distinguished inventor based in Vienna, Austria. With two notable patents to her credit, she has made significant contributions to the field of immunology, particularly in the development of vaccines aimed at combating HIV-1 infections. Her innovative work offers promising avenues for both therapeutic treatments and preventive measures against this life-threatening virus.

Latest Patents

Among her latest patents, Schmatz has disclosed antibodies that can be utilized in the manufacture of vaccines for both active and passive immunization. These antibodies are specifically designed for individuals in need of such treatments. The invention also emphasizes the use of human monoclonal antibodies that are functionally equivalent to those produced by cell lines CL1 through CL6, which are deposited at the European Collection of Animal Cell Cultures (ECACC) in the UK. Schmatz's patents also encompass hybridoma and CHO cell lines that produce the disclosed antibodies, as well as mixtures of these antibodies. Furthermore, her methods enable the detection, prevention, and therapeutic treatment of HIV-1 infections both in vitro and in vivo, underscoring her commitment to addressing a critical global health challenge.

Career Highlights

Christine Schmatz has worked with esteemed organizations such as Polynum Scientific Immunbiologische Forschung GmbH and Polymun Scientific Immunbiologische Forschung GmbH. Her tenure at these institutions has undoubtedly facilitated her exploration and development of groundbreaking innovations in the field of immunobiological research.

Collaborations

Throughout her career, Schmatz has collaborated with notable figures in her field, including Hermann W. Katinger and Andrea Buchacher. These partnerships have likely played a crucial role in advancing her research and expanding the impact of her inventions.

Conclusion

Christine Schmatz's contributions to the development of HIV vaccines highlight her position as a prominent inventor in the realm of medical innovation. With her dedication to finding effective solutions for HIV-1 infections, she continues to inspire future generations of scientists and inventors in the ongoing fight against this global health issue.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…